查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413223

亚磷酰胺市场：按类型、最终用户划分 - 全球预测 2024-2030

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), End-User (Academic & Research Institutions, Contract Research Organizations, Pharmaceutical & Biotechnology) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年亚磷酰胺市场规模为12.8亿美元，预计2024年将达13.8亿美元，2030年将达到21.3亿美元，复合年增长率为7.49%。

亚磷酰胺的全球市场

主要市场统计
基准年[2023] 12.8亿美元
预测年份 [2024] 13.8亿美元
预测年份 [2030] 21.3亿美元
复合年增长率（%） 7.49%
亚磷酰胺市场-IMG1

亚磷酰胺是一类常用于固相寡核苷酸合成中合成核酸（例如 DNA 和 RNA）的化合物。亚磷酰胺是有机磷化合物，含有透过氮原子与胺基连接的磷原子和各种保护基团以控制反应性。随着高通量序列测定技术的活性化，基因组学研究的兴起以及研究大规模遗传资讯的需求正在扩大亚磷酰胺的用途。人们对个人化医疗的日益关注正在推动对亚磷酰胺的需求，个人化医疗旨在根据个人的基因组成提供量身定制的医疗保健解决方案。与亚磷酰胺相关的高成本和可扩展性阻碍了市场成长。合成方法和亚磷酰胺技术的不断进步为提高效率、产量和成本效益提供了机会。

区域洞察

特别是在美国和加拿大，成熟的製药和生物技术产业正在推动对亚磷酰胺的需求，亚磷酰胺是合成核酸疗法和研究工具的重要组成部分。包括美国FDA 在内的监管机构正在为基于核酸的疗法的开发提供指导和支持，这正在推动亚磷酰胺在该地区的采用并推动市场成长。个人化医疗的努力正在不断增加，旨在根据个人的遗传资讯提供量身定制的医疗保健解决方案，预计将为欧洲、中东和非洲市场的亚磷酰胺製造商创造商机。亚太地区各国政府透过各种措施和资助计画积极支持生物技术和生命科学领域的发展。例如，中国推出「中国製造2025」倡议，推动包括生物技术在内的先进製造业发展。政府的支持和资助正在促进研究和开发活动，并为亚磷酰胺製造商创造合作机会并为市场成长做出贡献。

FPNV定位矩阵

FPNV定位矩阵对于评估亚磷酰胺市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对亚磷酰胺市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-亚磷酰胺市场的市场规模和预测是多少？

在 2-亚磷酰胺市场预测期间内，有哪些产品、细分市场、应用和领域值得考虑投资？

3-亚磷酰胺市场的技术趋势和法律规范是什么？

4-亚磷酰胺市场主要供应商的市场占有率为何？

进入5-亚磷酰胺市场的合适型态和策略手段有哪些？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基因研究、诊断、治疗和生物技术领域对寡核苷酸的需求不断增加
      • 随着序列测定技术的出现，基因组学研究不断取得进展
      • 製药和生物技术产业的扩张
    • 抑制因素
      • 亚磷酰胺合成的高成本和可扩展性问题
    • 机会
      • 亚磷酰胺合成方法与技术不断进步
      • 个人化医疗的进步带来巨大潜力
    • 任务
      • 与亚磷酰胺合成相关的环境与安全问题
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章亚磷酰胺市场：依类型

  • DNA亚磷酰胺
  • 染料标记的亚磷酰胺
  • RNA亚磷酰胺
  • 特殊亚磷酰胺

第七章亚磷酰胺市场：依最终用户分类

  • 学术/研究机构
  • 合约研究组织
  • 製药和生物技术

第八章 南北美洲亚磷酰胺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区亚磷酰胺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲亚磷酰胺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係

第12章竞争产品组合

  • 主要公司简介
    • AAT Bioquest, Inc.
    • Actylis
    • Amadis Chemical Company Limited
    • American International Chemical, LLC
    • Bioneer Corporation
    • Biosynth Ltd.
    • BOCSCI Inc.
    • ChemGenes Corporation
    • Creative Biolabs
    • Hongene Biotech Corporation
    • Huaren Science and Technology Co., Ltd.
    • Integrated DNA Technologies, Inc. by Danaher Corporation
    • LGC Limited
    • Lumiprobe Corporation
    • Maravai LifeSciences
    • MedChemExpress
    • Merck KGaA
    • PolyOrg, Inc.
    • QIAGEN NV
    • SBS Genetech Co., Ltd.
    • STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Tokyo Chemical Industry Co., Ltd.
    • Twist Bioscience Corporation
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-EA74537D7BA3

[190 Pages Report] The Phosphoramidite Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 7.49% to reach USD 2.13 billion by 2030.

Global Phosphoramidite Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.13 billion
CAGR (%) 7.49%
Phosphoramidite Market - IMG1

Phosphoramidite is a class of compounds commonly used to synthesize nucleic acids, such as DNA and RNA, during solid-phase oligonucleotide synthesis. Phosphoramidites are organic phosphorus compounds that contain a phosphorus atom bonded to an amino group through a nitrogen atom and various protecting groups to control reactivity. Growing genomics research activities with the advent of high-throughput sequencing technologies and the need for studying genetic information on a large scale are expanding the usage of phosphoramidite. Increasing focus on personalized medicine that aims to provide tailored healthcare solutions based on an individual's genetic makeup elevates the demand for phosphoramidite. High cost and scalability associated with phosphoramidite hampers market growth. Continuous advancements in synthesis methods and phosphoramidite techniques present opportunities for improvement in efficiency, yield, and cost-effectiveness.

Regional Insights

The presence of well-established pharmaceutical and biotechnology industries, particularly in the United States and Canada, drives the demand for phosphoramidites as essential building blocks in synthesizing nucleic acid-based therapeutics and research tools. Regulatory agencies, including the FDA in the United States, provide guidelines and support for the development of nucleic acid-based therapeutics, which facilitates the adoption of phosphoramidites in the region and encourages market growth. Increasing personalized medicine initiatives, which aim to provide tailored healthcare solutions based on an individual's genetic information, is expected to create opportunities for phosphoramidite manufacturers in the EMEA market. Governments in the Asia-Pacific region actively support the development of their biotechnology and life sciences sectors through various initiatives and funding programs. For instance, China has launched the "Made in China 2025" initiative to promote the development of advanced manufacturing, including biotechnology. Government support and funding facilitate research and development activities, creating opportunities for phosphoramidite manufacturers to collaborate and contribute to the market's growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Phosphoramidite Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Phosphoramidite Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC, Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Hongene Biotech Corporation, Huaren Science and Technology Co., Ltd., Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Limited, Lumiprobe Corporation, Maravai LifeSciences, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., SBS Genetech Co., Ltd., STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • DNA Phosphoramidites
    • Dye-Labeled Phosphoramidites
    • RNA Phosphoramidites
    • Speciality Phosphoramidites
  • End-User
    • Academic & Research Institutions
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Phosphoramidite Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Phosphoramidite Market?

3. What are the technology trends and regulatory frameworks in the Phosphoramidite Market?

4. What is the market share of the leading vendors in the Phosphoramidite Market?

5. Which modes and strategic moves are suitable for entering the Phosphoramidite Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Phosphoramidite Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for oligonucleotides in genetic research, diagnostics, therapeutics, and biotechnology
      • 5.1.1.2. Continuous advancements in genomics research with the advent of sequencing technologies
      • 5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous advancements in synthesis methods and techniques for phosphoramidites
      • 5.1.3.2. High potential owing to rising advancements in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Phosphoramidite Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Phosphoramidites
  • 6.3. Dye-Labeled Phosphoramidites
  • 6.4. RNA Phosphoramidites
  • 6.5. Speciality Phosphoramidites

7. Phosphoramidite Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutions
  • 7.3. Contract Research Organizations
  • 7.4. Pharmaceutical & Biotechnology

8. Americas Phosphoramidite Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Phosphoramidite Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Phosphoramidite Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Agreement, Collaboration, & Partnership
      • 11.3.1.1. Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AAT Bioquest, Inc.
    • 12.1.2. Actylis
    • 12.1.3. Amadis Chemical Company Limited
    • 12.1.4. American International Chemical, LLC
    • 12.1.5. Bioneer Corporation
    • 12.1.6. Biosynth Ltd.
    • 12.1.7. BOCSCI Inc.
    • 12.1.8. ChemGenes Corporation
    • 12.1.9. Creative Biolabs
    • 12.1.10. Hongene Biotech Corporation
    • 12.1.11. Huaren Science and Technology Co., Ltd.
    • 12.1.12. Integrated DNA Technologies, Inc. by Danaher Corporation
    • 12.1.13. LGC Limited
    • 12.1.14. Lumiprobe Corporation
    • 12.1.15. Maravai LifeSciences
    • 12.1.16. MedChemExpress
    • 12.1.17. Merck KGaA
    • 12.1.18. PolyOrg, Inc.
    • 12.1.19. QIAGEN N.V.
    • 12.1.20. SBS Genetech Co., Ltd.
    • 12.1.21. STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • 12.1.22. Thermo Fisher Scientific Inc.
    • 12.1.23. Tokyo Chemical Industry Co., Ltd.
    • 12.1.24. Twist Bioscience Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
  • FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PHOSPHORAMIDITE MARKET DYNAMICS
  • FIGURE 7. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. PHOSPHORAMIDITE MARKET LICENSE & PRICING